title: Nano-scale treatment for a macro-scale disease: nanoparticle-delivered siRNA silences CCR2 and treats myocarditis.
authors.affiliation: Division of Cardiology, Mayo Clinic, Rochester, MN, USA cooper.leslie@mayo.edu.
authors.forename: Leslie T
authors.initials: LT
authors.lastname: Cooper
authors.affiliation: Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA Johns Hopkins School of Medicine, Baltimore, MD, USA.
authors.forename: DeLisa
authors.initials: D
authors.lastname: Fairweather
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy*; D018932:Chemokine CCL2 / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009205:Myocarditis / Q000628:therapy*; D034741:RNA, Small Interfering / Q000494:pharmacology*
chemical_list: D018932:Chemokine CCL2; D034741:RNA, Small Interfering